| 2018-09-01 |
Lee HJ and Cha JY. Recent insights into the role of ChREBP in intestinal fructose absorption and metabolism. BMB Reports. 2018. Sep; 51(9):429-436. |
| 2018-01-01 |
Oh AR, Sohn S, Lee J, Park JM, Nam KT, Hahm KB, Kim YB, Lee HJ, Cha JY. ChREBP deficiency leads to diarrhea-predominant irritable bowel syndrome. Metabolism. 2018.85:286-297. |
| 2018-01-01 |
Roh JI, Lee J, Park SU, Kang YS, Lee J, OH AR, Choi DJ, Cha JY*, Lee HW*. CRISPR-Cas9-mediated generation of obese and diabetic mouse models. Experimental Animals. 2018. 67(2):229-237 *Correspondence |
| 2017-01-01 |
Cha JY, Park JM, Lee HJ, Bae JS, Han YM, Oh BC, Ko KH, Hahm KB. Emerging targets to relieve fat stress-induced liver diseases: UDCA, tocotrienol, ω-3 PUFAs, and IgY targeted NPC1L1 cholesterol transporter. Curr Pharm Des. 2017. 23(27):3941-3951. |
| 2017-01-01 |
Bae JS, Park JM, Lee J, Oh BC, Jang SH, Lee YB, Han YM, Ock CY, Cha JY*, Hahm KB* Amelioration of non-alcoholic fatty liver disease with NPC1L1-targeted IgY or n-3 polyunsaturated fatty acids in mice. Metabolism. 2017 66(1):32-44. *Correspondence |
| 2016-01-01 |
Bae JS, Oh AR, Lee HJ, Ahn YH, Cha JY. Hepatic Elovl6 gene expression is regulated by the synergistic action of ChREBP and SREBP-1c. Biochem Biophys Res Commun. (2016) 478(3):1060-6 |
| 2016-01-01 |
Oh AR, Bae JS, Lee J, Shin E, Oh BC, Park SC, Cha JY. Ursodeoxycholic acid decreases age-related adiposity and inflammation in mice. BMB Rep. 2016 49(2):105-10 |
